1059 - Immunotherapy: TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS γδTCR-BASED T CELL THERAPY

Uložené v:
Podrobná bibliografia
Vydané v:Cytotherapy (Oxford, England) Ročník 25; číslo 6; s. S240
Hlavní autori: Middendorp, S., Drent, E., Bisso, A., Baardman, S., Verweij, D., Salcedo, E., Coomans, C., Braem, S., van de Weg, S., Meijer, M., Proost, N., van de Ven, M., Norell, H., van Loenen, M., Emami, N., Melief, S., Gobessi, S., Throsby, M.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Elsevier Inc 01.05.2023
ISSN:1465-3249, 1477-2566
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Author Meijer, M.
Proost, N.
Middendorp, S.
Coomans, C.
van Loenen, M.
Emami, N.
van de Ven, M.
Melief, S.
Drent, E.
Verweij, D.
Throsby, M.
Baardman, S.
Bisso, A.
Norell, H.
Gobessi, S.
Braem, S.
van de Weg, S.
Salcedo, E.
Author_xml – sequence: 1
  givenname: S.
  surname: Middendorp
  fullname: Middendorp, S.
– sequence: 2
  givenname: E.
  surname: Drent
  fullname: Drent, E.
– sequence: 3
  givenname: A.
  surname: Bisso
  fullname: Bisso, A.
– sequence: 4
  givenname: S.
  surname: Baardman
  fullname: Baardman, S.
– sequence: 5
  givenname: D.
  surname: Verweij
  fullname: Verweij, D.
– sequence: 6
  givenname: E.
  surname: Salcedo
  fullname: Salcedo, E.
– sequence: 7
  givenname: C.
  surname: Coomans
  fullname: Coomans, C.
– sequence: 8
  givenname: S.
  surname: Braem
  fullname: Braem, S.
– sequence: 9
  givenname: S.
  surname: van de Weg
  fullname: van de Weg, S.
– sequence: 10
  givenname: M.
  surname: Meijer
  fullname: Meijer, M.
– sequence: 11
  givenname: N.
  surname: Proost
  fullname: Proost, N.
– sequence: 12
  givenname: M.
  surname: van de Ven
  fullname: van de Ven, M.
– sequence: 13
  givenname: H.
  surname: Norell
  fullname: Norell, H.
– sequence: 14
  givenname: M.
  surname: van Loenen
  fullname: van Loenen, M.
– sequence: 15
  givenname: N.
  surname: Emami
  fullname: Emami, N.
– sequence: 16
  givenname: S.
  surname: Melief
  fullname: Melief, S.
– sequence: 17
  givenname: S.
  surname: Gobessi
  fullname: Gobessi, S.
– sequence: 18
  givenname: M.
  surname: Throsby
  fullname: Throsby, M.
BookMark eNqNkM9Kw0AQhxepYK0-grBHBVf3T5JNBJE1TdNATCVZFU9LutlgNE2lqUKfS5-jz2Rae_LkaQbmN98M3yHoNfPGAHBC8AXBxLnMiOXYiFHLO6XsDGMHW4jvgT6xOEfUdpzept9FDsBh275iTLHr2n1QE2x7EMFoNvto5ssXs8jfV1dQijQMZJSEcPIo0kgk0BepHyWTOwGfIjmG4VB2jHMo4ChKM4miBPmxyDK4_lp_Sz9FtyILhlBCP4hjKMdBKu6fj8B-mdetOd7VAXgYBdIfo3gSRr6IkSEEc-QUtOy-m_LSo0VZMs3NVBtranturgtqUSfnLuasMC4xumRe4TFelN08Zw7Fhg3AzS_XdEc-K7NQra5Mo01RLYxeqmJeKYLVRp7aylMbM4oytZWneEe4_kPQddVUOq_fzOof-z_C2nHD
ContentType Journal Article
Copyright 2023 International Society for Cell & Gene Therapy
Copyright_xml – notice: 2023 International Society for Cell & Gene Therapy
DOI 10.1016/S1465-3249(23)00604-7
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1477-2566
EndPage S240
ExternalDocumentID S1465324923006047
GroupedDBID ---
--M
.1-
.FO
.~1
1P~
1~.
29F
36B
4.4
457
4G.
53G
5GY
5VS
7-5
8P~
AAAJQ
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AATTM
AAXKI
AAXUO
AAYWO
ABDBF
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ABXDB
ACDAQ
ACGEJ
ACGFS
ACIEU
ACLOT
ACRLP
ACUHS
ACVFH
ADBBV
ADCNI
ADCVX
ADEZE
ADXPE
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFKVX
AFPUW
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGRDE
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AJWEG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AWYRJ
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CJTIS
COF
CS3
DU5
EAP
EBC
EBS
EFJIC
EFKBS
EFLBG
EJD
EMB
EMK
EMOBN
ESX
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
GBLVA
H13
HVGLF
HZ~
KOM
LUGTX
M44
MO0
O-L
O9.
OAUVE
OK~
P-8
P-9
P2P
PC.
Q38
R2-
ROL
SDF
SPCBC
SSH
SSI
SSU
SSZ
SV3
T5K
TDBHL
TFW
Z5R
~G-
~HD
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
DOVZS
LCYCR
ID FETCH-LOGICAL-e1107-6d2f088b7f92dff3c7ebce4b598acd2426a78073de81ecf39d937dfb59a3620e3
ISSN 1465-3249
IngestDate Fri Feb 23 02:37:14 EST 2024
Tue Oct 14 19:31:04 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-e1107-6d2f088b7f92dff3c7ebce4b598acd2426a78073de81ecf39d937dfb59a3620e3
ParticipantIDs elsevier_sciencedirect_doi_10_1016_S1465_3249_23_00604_7
elsevier_clinicalkey_doi_10_1016_S1465_3249_23_00604_7
PublicationCentury 2000
PublicationDate May 2023
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: May 2023
PublicationDecade 2020
PublicationTitle Cytotherapy (Oxford, England)
PublicationYear 2023
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0020885
Score 2.350552
SourceID elsevier
SourceType Publisher
StartPage S240
Title 1059 - Immunotherapy: TARGETING OVARIAN CARCINOMA WITH GDT002, A FIRST-IN-CLASS γδTCR-BASED T CELL THERAPY
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1465324923006047
https://dx.doi.org/10.1016/S1465-3249(23)00604-7
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: ScienceDirect database
  customDbUrl:
  eissn: 1477-2566
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0020885
  issn: 1465-3249
  databaseCode: AIEXJ
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVAWR
  databaseName: Taylor and Francis Online Journals
  customDbUrl:
  eissn: 1477-2566
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0020885
  issn: 1465-3249
  databaseCode: TFW
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZKxwMviKsYN_kBJlDmrcs9vKVZtgaxrkoN6luUxLaENGWoK1P7u-Cdf7DfxHHsXCoeuEi8RK1rx5HP1-PjE3-fEXpljdio8Er5zlCmbtgRJ3npcGIHlihzh8k3UfVhE9506i8WwWww-NFwYa4vvKry1-vgy381NZSBsSV19i_M3d4UCuAzGB2uYHa4_pHhZShjECORxA9Nr6pVnWiYnsZUJqfOP4VpEk6NKEyjZHp-Br4hoRPj9JjWQqnSWZwk6ZySZEqiD-EclvpR_Hps1VebRikZh_P42KBGJNNedBKn4WwrzI02q6brWs903Wyh12eG9PIPZ1LDpGKXy_qgvPlBG1lL2ai6SVs0BpAoVk5XlAPCmyTuQT-FYfY2DKq8WsOt2dr6CS7cIRDuqefhusyTuhLqnJbGfyvitMZp3xnPTaUEpSf25usvk4bKX8zbDmFcpJxFILVqbOJ1M2W7f7GuK6vCAk5W8m6hHdNzAn-IdsIkXrxv1_zgxB1FcFP37khkh12Hb0zrre6sFxP14hx6D93VCxQcKmDdRwNePUB7M6VwvtnHtCPsXe3jPTzrtM83D9GFRB8meAt973CLPayxh1vsYYk9rLC3j0O8jTx88-3me4s4TLFEHNaIe4Q-nsQ0mhB9oAfhMs1AXGYKGJDCE4HJhLBKjxcltwsYuLxkMljMPR_mHMb9I14KK2AQPDMBv-cQZ4249RgNq8uKP0FYFD73BXeF6wibs7zILdsZCctinu-6nO8itxnHrOEYw6yYgc2zdmOjNEAmDZCZVlYbIPN2kd821EGoCi5_3_Tpvzd9hu50f4znaLhafuUv0O3yevX5avlSg-oneH-VDQ
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1059+-+Immunotherapy%3A+TARGETING+OVARIAN+CARCINOMA+WITH+GDT002%2C+A+FIRST-IN-CLASS+%CE%B3%CE%B4TCR-BASED+T+CELL+THERAPY&rft.jtitle=Cytotherapy+%28Oxford%2C+England%29&rft.au=Middendorp%2C+S.&rft.au=Drent%2C+E.&rft.au=Bisso%2C+A.&rft.au=Baardman%2C+S.&rft.date=2023-05-01&rft.pub=Elsevier+Inc&rft.issn=1465-3249&rft.eissn=1477-2566&rft.volume=25&rft.issue=6&rft.spage=S240&rft.epage=S240&rft_id=info:doi/10.1016%2FS1465-3249%2823%2900604-7&rft.externalDocID=S1465324923006047
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-3249&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-3249&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-3249&client=summon